
Company Info
Year Established2019
Ticker
PRME
Exchange
NASDAQ
Contacts
Richard BrudnickCBO
Keith Gottesdiener, MD
Prsident & CEO
Jeremy Duffield, MD, PhD, FRCP
CSO
Ann Lee, PhD
CTO
Carman Alenson, CPA
Interim CAO & CFO
Jeremy Duffield, MD, PhD, FRCP
CSO
Company Description
Prime Medicine uses Prime Editing, a next-generation technology that can 'search and replace' to restore normal genetic function almost anywhere in the genome.
